Overview
REPL market data
Price History
REPL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.38 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.97 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.50 – $12.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $438.7 · P/B 3.80.
Company News
Replimune Lead Drug Trial Data Deemed 'Not Interpretable' by FDA StaffBenzinga · Jul 28, 2026, 6:09 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Jul 28, 2026, 5:06 PM
Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jun 30, 2026, 1:10 PM
Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $9Benzinga · Jun 30, 2026, 12:55 PM
Replimune Group Q4 EPS $(0.76) Misses $(0.71) EstimateBenzinga · Jun 29, 2026, 1:00 PM
8-K filing — Replimune Group, Inc. (REPL)SEC EDGAR · Jun 29, 2026, 12:11 PM
What's Going On With Capricor Therapeutics Stock On Friday?Benzinga · Jun 26, 2026, 6:10 PM
Replimune Group Says FDA Accepts Resubmission Of BLA For RP1 In Combination With Nivolumab For Advanced Melanoma, With August 2 Goal Date And Expects Adcom Meeting In Late JulyBenzinga · Jun 26, 2026, 12:10 PM
Regenxbio Gains Fresh Chance As FDA Reconsiders Gene TherapyBenzinga · Jun 22, 2026, 1:25 PM
Optimum Communications, Fluence Energy, Virgin Galactic And Other Big Stocks Moving Higher TodayBenzinga · Jun 1, 2026, 3:13 PM